Background Public and medical interest in cannabidiol (CBD) has been rising, and CBD is
now available from various sources. Research into the effects of low-dose CBD on outcomes …

Introduction: Preclinical and clinical studies suggest that cannabidiol (CBD) found in
Cannabis spp. has broad therapeutic value. CBD products can currently be purchased …

Introduction: Chronic cannabis use has been associated with impaired cognition and
elevated psychological symptoms, particularly psychotic-like experiences. While Δ9 …

Background Cannabidiol (CBD) is a primary component in the cannabis plant; however, in
recent years, interest in CBD treatments has outpaced scientific research and regulatory …

The recreational use of cannabis can have persistent adverse effects on mental health.
Delta-9-tetrahydrocannabinol (THC) is the main psychoactive constituent of cannabis, and …

Anxiety disorders have the highest lifetime prevalence of any mental illness worldwide,
leading to high societal costs and economic burden. Current pharmacotherapies for anxiety …

Global interest in the non‐intoxicating cannabis constituent, cannabidiol (CBD), is
increasing with claims of therapeutic effects across a diversity of health conditions. At …

Cannabidiol (CBD) has become a fast-growing avenue for research in psychiatry, and
clinicians are challenged with understanding the implications of CBD for treating mental …

Cannabidiol (CBD), a Cannabis sativa constituent, is a pharmacologically broad-spectrum
drug that in recent years has drawn increasing interest as a treatment for a range of …

Background The therapeutic application of cannabidiol (CBD) is gaining interest due to
expanding evidence for its use. Objective To summarize the clinical outcomes, study …